Zoal Everyone needs help : Meet the team at Harambee Food Pantry that helps serve thousands monthly
U.S. health officials have asked doctors to prioritize which infants get the new RSV shot, just ascases of the respiratory diseasebegin to rise with the onset of cold and flu season.Due to a limited supply, the Centers for Disease Control and Pre <a href=https://www.stanley-cups.de>stanley becher</a> vent <a href=https://www.stanley-cup.it>stanley cup</a> ion is recommending pediatricians and health care providers reserve doses of the new monoclonal antibody drug, nirsevimab, for those at highest risk of severe respiratory syncytial virus, which includes infants under 6 months and those with underlying conditions.The federal agency is also recommending doctors stop giving the shot, which is sold under the brand name Beyfortus, to infants 8 to 19 months old who are eligible for palivizumab, an older antibody injection sold under the brand name Synagis used to prevent severeRSVin children at increased risk due to heart and lung conditions.RSV is a common respiratory virus the can become serious in young children, older people and those with weaker immune systems. Most infants are infected in their fir <a href=https://www.stanley1913.com.es>vaso stanley</a> st year of life, and it s the leading cause of hospitalization among the age group, the CDC states.In addressing the great need for RSV prevention products, the FDAapproved Beyfortusfor newborns and infants in July, and th |